FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula 
for application in the manufacture and delivery of conjugated molecules, such as low molecular compounds, peptides, nucleic acids, fluorescent molecules and polymers, which are connected with the integrin antagonists of alpha-V-beta-3, to target the cells expressing alpha-V-beta-3.
EFFECT: improved properties.
17 cl, 10 dwg, 1 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONJUGATES FOR INTEGRIN ANTAGONIST TARGETED DELIVERY TO CELLS, EXPRESSING LFA-1 | 2013 |
|
RU2624732C2 |
| CONJUGATES FOR INTEGRIN ANTAGONIST TARGETED DELIVERY TO CELLS, EXPRESSING LFA-1 | 2013 |
|
RU2624731C2 |
| DERIVATIVES OF THIAZOLE, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1999 |
|
RU2218337C2 |
| DERIVATIVES OF THIAZOLE, METHOD OF THEIR SYNTHESIS, COMPOSITION BASED ON THEREOF AND INTERMEDIATE COMPOUND | 1999 |
|
RU2166503C2 |
| ARYLCARBONYL DERIVATIVES AS THERAPEUTIC AGENTS | 2003 |
|
RU2340605C2 |
| PYRIMIDINE COMPOUNDS (VERSIONS), METHODS FOR PREPARING THEM, COMPOSITIONS CONTAINING THEM AND METHOD OF TREATING DISEASES RELATED TO mTOR KINASE OR PI3K KINASE | 2010 |
|
RU2538200C2 |
| BENZYLAMINE DERIVATIVES AS INHIBITORS OF PLASMA KALLIKREIN | 2012 |
|
RU2607045C2 |
| TETRAHYDROCARBAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITION AND THERAPEUTIC AGENT THEREOF, METHOD OF TREATING AND/OR PREVENTING PHYSIOLOGICAL AND/OR PATHOLOGICAL CONDITIONS MEDIATED BY LHRH RECEPTOR BY ABOVE DERIVATIVES | 2008 |
|
RU2497806C9 |
| QUINOLINE AND QUINOXALINE DERIVATIVES EFFECTIVE AS CYSTEINYL-LEUKOTRIENE ANTAGONISTS | 2012 |
|
RU2605929C2 |
| LOW-MOLECULAR CONJUGATES FOR INTRACELLULAR DELIVERY OF BIOLOGICALLY ACTIVE COMPOUNDS | 2011 |
|
RU2629957C2 |
